ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,239,749 | +317.0% | 187,030 | +365.9% | 0.01% | +400.0% |
| Q2 2023 | $1,256,475 | -45.7% | 40,143 | -51.1% | 0.00% | -60.0% |
| Q1 2023 | $2,315,159 | -54.3% | 82,127 | -57.6% | 0.01% | -50.0% |
| Q4 2022 | $5,063,443 | +21.8% | 193,779 | +4.0% | 0.01% | +11.1% |
| Q3 2022 | $4,158,000 | -14.4% | 186,287 | +14.2% | 0.01% | -10.0% |
| Q2 2022 | $4,857,000 | +5.5% | 163,136 | -6.8% | 0.01% | +25.0% |
| Q1 2022 | $4,604,000 | -41.7% | 175,030 | -48.5% | 0.01% | -38.5% |
| Q4 2021 | $7,901,000 | -36.0% | 339,725 | -15.2% | 0.01% | -38.1% |
| Q3 2021 | $12,353,000 | +24.3% | 400,628 | -1.2% | 0.02% | +23.5% |
| Q2 2021 | $9,937,000 | -28.5% | 405,311 | -45.6% | 0.02% | -32.0% |
| Q1 2021 | $13,904,000 | -15.3% | 744,483 | -9.2% | 0.02% | -21.9% |
| Q4 2020 | $16,415,000 | +19.9% | 820,359 | -0.8% | 0.03% | +10.3% |
| Q3 2020 | $13,690,000 | -11.1% | 826,703 | +4.1% | 0.03% | -14.7% |
| Q2 2020 | $15,403,000 | +78.2% | 794,236 | +32.4% | 0.03% | +54.5% |
| Q1 2020 | $8,644,000 | -28.9% | 599,825 | +0.3% | 0.02% | -4.3% |
| Q4 2019 | $12,162,000 | +175.4% | 597,773 | +164.3% | 0.02% | +155.6% |
| Q3 2019 | $4,416,000 | +3.1% | 226,159 | +18.7% | 0.01% | +12.5% |
| Q2 2019 | $4,282,000 | -53.1% | 190,558 | -24.1% | 0.01% | -52.9% |
| Q1 2019 | $9,129,000 | +54.1% | 250,922 | +24.3% | 0.02% | +30.8% |
| Q4 2018 | $5,925,000 | +157.3% | 201,833 | +272.3% | 0.01% | +225.0% |
| Q3 2018 | $2,303,000 | +796.1% | 54,217 | +767.3% | 0.00% | +300.0% |
| Q2 2018 | $257,000 | -96.2% | 6,251 | -94.6% | 0.00% | -90.9% |
| Q1 2018 | $6,681,000 | -33.5% | 115,274 | -36.4% | 0.01% | -35.3% |
| Q4 2017 | $10,042,000 | +122.2% | 181,310 | +103.9% | 0.02% | +112.5% |
| Q3 2017 | $4,520,000 | +1730.0% | 88,903 | +1990.4% | 0.01% | – |
| Q2 2017 | $247,000 | -57.0% | 4,253 | -56.8% | 0.00% | -100.0% |
| Q1 2017 | $575,000 | +31.0% | 9,835 | +23.6% | 0.00% | 0.0% |
| Q4 2016 | $439,000 | – | 7,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |